Trial of Andexanet Alfa in ICrH Patients Receiving an Oral FXa Inhibitor
Clinical trial NCT03661528 · COMPLETED
Trial details
- NCT number
- NCT03661528
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-06
- Primary completion
- 2023-05-27
- Enrollment
- 530
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.